全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Xp11.2易位/TFE3基因融合相关性肾癌成人病例1例
An Adult Case of Renal Carcinoma Associated with Xp11.2 Translocation/TFE3 Gene Fusion

DOI: 10.12677/ACM.2023.1351122, PP. 8014-8019

Keywords: 肾癌,TFE3,免疫组化,荧光原位杂交,靶向治疗
Kidney Cancer
, TFE3, Immunohistochemistry, Fluorescence in Situ Hybridization, Targeted Therapy

Full-Text   Cite this paper   Add to My Lib

Abstract:

Xp11.2易位/TFE3基因融合相关性肾癌是一种非常罕见的肾肿瘤亚型,多发生于儿童,早期即可发生转移。本病主要临床表现包括无痛性肉眼血尿、腹部肿块和患侧腰痛,其中大约三分之一的患者是无症状的。本病的诊断主要依靠组织病理学特征和免疫表型及基因检测,影像学检查较难诊断。本文报道1例成年男性患者的Xp11.2易位/TFE3基因融合相关性肾癌病例。该患者为21岁的成年男性,于入院7天前经查体发现左肾占位,无明显的临床表现。本文通过文献复习Xp11.2易位/TFE3基因融合相关性肾癌的发病机制、流行病学、临床表现、影像学特点、病理学特点、治疗及预后,旨在提高对该病的认识。
Xp11.2 translocation/TFE3 gene fusion-associated renal carcinoma is a rare RCC subtype, which oc-curs mostly in children and can metastasize early. The main clinical manifestations of this disease include painless gross hematuria, abdominal mass, and low back pain on the affected side. About a third of patients are asymptomatic. The diagnosis of this disease mainly depends on histopatholog-ical features, immunophenotype, and genetic testing, while imaging examination is difficult to di-agnose. In this article, one case of Xp11.2 translocation/TFE3 gene fusion-associated renal carcino-ma was reported. The patient was a 21-year-old man who revealed a left kidney occupied by ultra-sound for seven days. No other notable clinical symptoms were identified. In this article, literature review was performed to investigate the pathogenesis, epidemiology, clinical manifestations, imag-ing features, pathological features, treatment, and prognosis of Xp11.2 translocation/TFE3 gene fu-sion-associated renal carcinoma, and summarize the diagnosis and treatment experience of this case.

References

[1]  Lopez-Beltran, A., Scarpelli, M., Rodolfo, M., et al. (2006) 2004 WHO Classification of the Renal Tumors of the Adults. European Urology, 49, 798-805.
https://doi.org/10.1016/j.eururo.2005.11.035
[2]  Calio, A., Segala, D., Munari, E., et al. (2019) MiT Family Translocation Renal Cell Carcinoma: From the Early Descriptions to the Current Knowledge. Cancers (Basel), 11, Article No. 1110.
https://doi.org/10.3390/cancers11081110
[3]  Al-Maghrabi, J.A. and Khabaz, M.N. (2020) Uncommon Localization of Extrarenal Xp11.2 Translocation-Associated Renal Cell Carcinoma (RCC): Case Report. Applied Immunohistochemistry & Molecular Morphology, 28, E33-E35.
https://doi.org/10.1097/PAI.0000000000000576
[4]  Tomlinson, G.E., Nisen, P.D., Timmons, C.F., et al. (1991) Cytogenetics of a Renal-Cell Carcinoma in a 17-Month-Old Child—Evidence for XP11.2 as a Recurring Breakpoint. Cancer Genetics and Cytogenetics, 57, 11-17.
https://doi.org/10.1016/0165-4608(91)90184-V
[5]  Muller-Hocker, J., Babaryka, G., Schmid, I., et al. (2008) Overexpression of Cyclin D1, D3, and p21 in an Infantile Renal Carcinoma with Xp11.2 TFE3-Gene Fusion. Pathology Research and Practice, 204, 589-597.
https://doi.org/10.1016/j.prp.2008.01.010
[6]  Argani, P., Lae, M., Ballard, E.T., et al. (2006) Translocation Car-cinomas of the Kidney after Chemotherapy in Childhood. Journal of Clinical Oncology, 24, 1529-1534.
https://doi.org/10.1200/JCO.2005.04.4693
[7]  Cimadamore, A., Cheng, L., Scarpelli, M., et al. (2021) Towards a New WHO Classification of Renal Cell Tumor: What the Clinician Needs to Know—A Narrative Review. Translational Andrology and Urology, 10, 1506-1520.
https://doi.org/10.21037/tau-20-1150
[8]  朱庆强, 王中秋, 吴晶涛, 等. XP11.2易位TFE基因融合相关性肾癌的多层螺旋CT表现[J]. 中华放射学杂志, 2012, 46(6): 516-520.
[9]  陶磊, 崔文静, 刘丽, 等. Xp11.2易位/TFE3基因融合相关性肾癌影像表现及病理对照[J]. 临床放射学杂志, 2016, 35(8): 1190-1195.
[10]  Chen, X., Zhu, Q.Q., Li, B.X., et al. (2017) Renal Cell Carcinoma Associated with Xp11.2 Translocation/TFE Gene Fusion: Imaging Findings in 21 Patients. European Radiology, 27, 543-552.
https://doi.org/10.1007/s00330-016-4421-4
[11]  Wang, W., Ding, J.H., Li, Y., et al. (2014) Magnetic Resonance Imaging and Computed Tomography Characteristics of Renal Cell Carcinoma Associated with Xp11.2 Transloca-tion/TFE3 Gene Fusion. PLOS ONE, 9, e99990.
https://doi.org/10.1371/journal.pone.0099990
[12]  Kato, H., Kanematsu, M., Yokoi, S., et al. (2011) Renal Cell Carcinoma Associated with Xp11.2 Translocation/TFE3 Gene Fusion: Radiological Findings Mimicking Papillary Sub-type. Journal of Magnetic Resonance Imaging, 33, 217-220.
https://doi.org/10.1002/jmri.22392
[13]  丁文双, 刘国荣, 常丽君, 等. Xp11tRCC与TFE3阳性非Xp11tRCC的临床病理特征分析[J]. 贵州医科大学学报, 2021, 46(8): 970-975.
[14]  Karashima, T., Kuno, T., Kuroda, N., et al. (2018) Bilateral Xp11.2 Translocation Renal Cell Carcinoma: A Case Report. BMC Urology, 18, Article No. 6.
https://doi.org/10.1186/s12894-018-0419-3
[15]  Yang, B., Duan, H.Q., Cao, W.F., et al. (2019) Xp11 Translocation Renal Cell Carcinoma and Clear Cell Renal Cell Carcinoma with TFE3 Strong Positive Immunostaining: Morphology, Immunohistochemistry, and FISH Analysis. Modern Pathology, 32, 1521-1535.
https://doi.org/10.1038/s41379-019-0283-z
[16]  王晓敏, 付刚, 任力. Xp11.2易位/TFE3基因融合相关性肾细胞癌5例临床病理及基因融合分析[J]. 诊断病理学杂志, 2019, 26(6): 338-340.
[17]  Klatte, T., Streubel, B., Wrba, F., et al. (2012) Renal Cell Carcinoma Associated with Transcription Factor E3 Expression and Xp11.2 Translocation Incidence, Characteristics, and Prognosis. American Journal of Clinical Pathology, 137, 761-768.
https://doi.org/10.1309/AJCPQ6LLFMC4OXGC
[18]  Williamson, S.R., Gill, A.J., Argani, P., et al. (2020) Report from the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Uro-genital Cancers III: Molecular Pathology of Kidney Cancer. American Journal of Surgical Pathology, 44, E47-E65.
https://doi.org/10.1097/PAS.0000000000001476
[19]  Malouf, G.G., Monzon, F.A., Couturier, J., et al. (2013) Genomic Heterogeneity of Translocation Renal Cell Carcinoma. Clinical Cancer Research, 19, 4673-4684.
https://doi.org/10.1158/1078-0432.CCR-12-3825
[20]  Ma, W.L., Liu, N., Zhuang, W.Y., et al. (2020) Comparative Clinicopathologic Characteristics and Outcomes of Paediatric and Adult Xp11 Translocation Renal Cell Carcinomas: A Retrospective Multicentre Study in China. Scientific Reports, 10, Article No. 2249.
https://doi.org/10.1038/s41598-020-59162-5
[21]  Chang, K., Qu, Y.Y., Dai, B., et al. (2017) PD-L1 Expression in Xp11.2 Translocation Renal Cell Carcinoma: Indicator of Tumor Aggressiveness. Scientific Reports, 7, Article No. 2074.
https://doi.org/10.1038/s41598-017-02005-7

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133